Differential symptom cluster responses to repetitive transcranial magnetic stimulation (rTMS) treatment in depression
Everyone experiences depression differently. Few studies have looked at how individual symptoms change across treatment, and how they might be related. Specifically, this study was interested in individuals with treatment-resistant depression and how they respond to new, effective repetitive transcranial magnetic stimulation (rTMS) treatments (or the shortened version, iTBS).
Evaluation of the effects of rTMS on self-reported quality of life and disability in treatment-resistant depression: A THREE-D study
Depression doesn’t just affect mood. It also impacts an individual’s ability to function in daily life. This study explored how the use of rTMS and iTBS as new, safe, non-invasive, and effective treatment(s) for treatment-resistant depression affected individuals’ quality of life and levels of disability.
Understanding the Common Side Effect of Pain During Repetitive Transcranial Magnetic Stimulation Treatment
The symptoms of depression are bad enough without enduring side effects from the medications used to treat them. Newer treatments without drugs include repetitive transcranial magnetic stimulation (rTMS), a non-invasive procedure where patients receive a series of short magnetic pulses over the scalp to stimulate the nerve cells of the brain. Daily 40-minute treatments using a protocol called high-frequency stimulation (HF) are delivered for 6 weeks, however this can be shortened to daily 3-minute treatments using a protocol called intermittent theta burst stimulation (iTBS).
Predicting Response Trajectories for Suicidal Ideation and Negative Mood among Patients with Depression receiving rTMS
Repetitive Transcranial Magnetic Stimulation (rTMS) therapy has been found to be a non-invasive, safe, and effective way of treating depression – even in individuals who do not respond to usual antidepressant medications. In this study, we were interested in how rTMS changed people’s depressed mood and suicidal thoughts.
NINET-IMH HTAC Survey Results Summary
Written By. Kevin Jiang Last January, NINET-IMH team sent out a survey to the clinic patients asking about their opinions on making rTMS publicly funded in BC, as well as to share their experiences receiving rTMS treatments.In the hopes of reinforcing the lab’s application of nominating rTMS to the BC Health Technology Assessment Committee (HTAC) […]
Side Effects Trajectories in rTMS Treatment for Depression
Side Effects Trajectories in rTMS Treatment for Depression: High Frequency Left (10Hz) vs. Intermittent Theta Burst Stimulation Afifa Humaira, Sihaoyu Gao , Lang Wu, Jonathan Downar, Daniel Blumberger, Fidel Vila-Rodriguez Introduction According to WHO, Major Depressive Disorder (MDD) is a leading cause of disability that affects 350 million people worldwide, and 30% of them suffer […]
Long term effects of rTMS
Long term effects of rTMS on the Functional Brain Networks in Treatment-resistant Depression Ruiyang Ge , Jonathan Downar, Daniel M. Blumberger, Zafiris J. Daskalakis, Raymond Lam & Fidel Vila-Rodriguez Background Major Depressive Disorder (MDD) MDD is a severe disabling and highly prevalent disorder with substantial societal costs. Approximately 60% of the patients do not achieve […]
HTAC Survey Results
HTAC Survey Results Show Support for Provincial rTMS Funding By. Kevin Jiang “I have struggled with cyclical depression for approximately 20 years. I have tried many medications and alternative treatments. rTMS has proven to be the most effective treatment I have found.” The NINET-IMH Clinic & Laboratory has submitted a nomination to […]
NINET-IMH Newsletter (February 2019)
February 2019 www.ninet.med.ubc.ca PDF version of the newsletter can be found here Note from the PAC Members Dear reader, This monthly newsletter is brought to you by NINET’s Public Advisory Committee (PAC) members. The PAC consist of members of the public, clinic patients, lab personnel, and Dr. Vila-Rodriguez. We meet once a month to discuss […]
Patient Centered Research
Patient-Centred Research: New Research from the NINET Lab on the Side Effects Associated with rTMS One of the most critical aspects of clinical practice is to have up to date information on both the benefits and risks associated to a therapeutic intervention. They both equally important for patients and clinicians to inform decisions related to […]